Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.
Also called NCT03844594
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 220 participants
- Registry
-
NCT03844594
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03844594. Allocation not applicable; no masking; primary purpose treatment. Start 2019-04-06 (actual); primary completion 2020-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Eptifibatide Injection
- Lead sponsor
- Ministry of Science and Technology of the People´s Republic of China
Record details
- Record id
cardio:ct-nct03844594- Content hash
3eee5c29417de8f1caba940513518826a137099d3647c11f03c038118f1b7198